Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000905718-18-000981

Director sold 72,934 shares at an average $29.85 ($2,176,898)

From the SEC's structured data for this filing

Trades in this filing

EMSTER KURT VON · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-12-17 Sale : show line 1 in the form −3,009 $33.17 $99,797 1,234,193 I
2018-12-18 Sale : show line 2 in the form −69,925 $29.70 $2,077,101 1,164,268 I
Open-market sales · 72,934 sh · avg $29.85 · $2,176,898
Loading xslF345X03/crisprfm4_dec172018.xml…